Announcements Trials
Browse Landscape

Phase

Phase NA 44Phase 2 6Phase 1 4Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain 4Neoplasms 3Fatigue 3Pancreatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Polycystic Ovary Syndrome 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Depression 1Breast Neoplasms 1Anxiety Disorders 1Agnosia 1

Interventions

Cyclophosphamide 149Docetaxel 139Paclitaxel 127Trastuzumab 120Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Acupuncture Therapy × Clear all
NCT00957112 2013-08-26

Acupuncture or Self-Acupuncture in Managing Cancer-Related Fatigue in Women Who Have Received Chemotherapy for Stage I, Stage II, or Stage IIIA Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
320 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡